IRWD

Ironwood Pharmaceuticals Inc.

Price

$3.62

return (12m)

133.55%

p/e

4.58

p/bv

-3.68

DIVIDEND YIELD

0.00%

IRWD price

Ironwood Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IRWD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-15.22%

3 months

-17.54%

1 year

133.55%

2 years

-14.42%

5 years

-72.84%

10 years

-76.91%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals IRWD

Valuation

P/E

4.58

Sector -3.46

Industry -3.46

P/BV

-3.68

Sector 1.94

Industry 1.94

P/Revenue (PSR)

1.53

Sector 1.96

Industry 1.96

EV/EBITDA

6.34

Sector -216.42

Industry -216.42

EV/EBIT

6.38

Sector -46.11

Industry -46.11

P/EBITDA

2.46

Sector -21.02

Industry -21.02

P/EBIT

2.48

Sector -27.60

Industry -27.60

P/Total Assets

2.09

Sector 1.14

Industry 1.14

P/Net Current Assets

-2.40

Sector -10.24

Industry -10.24

P/Working Capital

3.58

Sector -162.19

Industry -162.19

EPS

0.79

Sector -1.78

Industry -1.78

BVPS

-0.98

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

100.00%

Sector 41.35%

Industry 41.35%

EBITDA Margin

72.00%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

71.60%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

60.15%

Sector -35.47%

Industry -35.47%

Net Profit Margins

33.36%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.40

Sector 0.03

Industry 0.03

Profitability

ROE

-80.24%

Sector -57.40%

Industry -57.40%

ROA

45.55%

Sector -59.43%

Industry -59.43%

ROIC

86.87%

Sector -2,370.21%

Industry -2,370.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

6.06

Sector 2.91

Industry 2.91

Net Debt / EBITDA

-0.97

Sector -21.98

Industry -21.98

Net Debt / EBIT

-0.98

Sector -8.44

Industry -8.44

Net Debt / Equity

0.49

Sector -33,112.99

Industry -33,112.99

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

-0.57

Sector 0.46

Industry 0.46

Liabilities/Assets

1.57

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-1.21%

Sector -

Industry -

5Y Earnings CAGR

-24.47%

Sector -

Industry -

Fundamentals IRWD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IRWD Ironwood Pharmaceuticals Inc.	$3.62	147.95%	0.00%	4.58	-3.68	-80.24%	33.36%
PFE Pfizer Inc.	$27.48	8.11%	6.26%	36.14	1.83	5.07%	6.80%
ABBV AbbVie Inc.	$259.97	9.77%	2.63%	72.88	-77.57	-106.44%	9.81%
NVO Novo Nordisk A/S	$37.23	-33.47%	4.98%	9.10	4.83	53.11%	35.32%
MRK Merck & Co. Inc.	$143.18	65.09%	2.36%	110.80	8.37	7.56%	4.77%
AZN AstraZeneca PLC	$156.59	-4.79%	2.06%	18.71	4.82	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.33	34.59%	4.20%	13.14	5.46	41.59%	18.87%
ZTS Zoetis Inc.	$69.46	-51.82%	3.01%	11.00	9.21	83.77%	27.69%
AMGN Amgen Inc.	$402.15	38.44%	2.47%	24.84	18.58	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$729.88	22.13%	0.51%	17.33	2.37	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$108.98	45.42%	0.00%	30.90	89.03	288.13%	24.86%
MCK McKesson Corporation	$888.29	16.56%	0.38%	22.96	-27.29	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$501.27	24.01%	0.00%	28.87	6.28	21.76%	35.00%
CAH Cardinal Health Inc.	$226.17	45.05%	0.91%	30.94	-19.47	-62.92%	0.67%
ARGX argenx SE	$914.13	19.13%	0.00%	20.47	5.36	26.20%	25.70%
HRMY Harmony Biosciences Holdings Inc.	$39.41	46.40%	0.00%	12.60	2.28	18.14%	18.88%
BIIB Biogen Inc.	$220.34	42.87%	0.00%	38.99	1.73	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IRWD - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

2010

Time since IPO - 16 years

674

Employees

Ironwood Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $595.16 million, with shareholders equity totaling $-161.84 million.

The company employs approximately 674 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ironwood Pharmaceuticals Inc. reported $389.32 million in revenue, generating net income of $129.87 million.

Key financial metrics include a P/E ratio of 4.58, a price-to-book (P/B) ratio of -3.68, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IRWD.

Market cap

$595.16 million

Net worth

$-161.84 million

$-161,843,000.00

Assets

$285.13 million

$285,128,000.00

Total Shares Outstanding

164.41 million

164,405,000

Average Daily Trading Volume

$2.07 million

$2,066,780.68

Sector

Health Care

Industry

Biotechnology

IRWD

IRWD revenue and profits

Financial Results IRWD

DRAG THE FRAME TO SEE MORE DATA

IRWD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$888.29 20,83% (12M)

P/E

22.96

0.38%

ROE

-118.84%

P/BV

-27.29

CAH - Cardinal Health

$226.17 47,96% (12M)

P/E

30.94

0.91%

ROE

-62.92%

P/BV

-19.47

ABBV - AbbVie

$259.97 14,69% (12M)

P/E

72.88

2.63%

ROE

-106.44%

P/BV

-77.57

MRK - Merck & Co.

$143.18 65,85% (12M)

P/E

110.80

2.36%

ROE

7.56%

P/BV

8.37

AZN - AstraZeneca

$156.59 --6,84% (12M)

P/E

18.71

2.06%

ROE

25.77%

P/BV

4.82

PFE - Pfizer

$27.48 7,47% (12M)

P/E

36.14

6.26%

ROE

5.07%

P/BV

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12M)

P/E

13.14

4.20%

ROE

41.59%

P/BV

5.46

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$888.29 20,83% (12 M)

P/L

22.96

0.38%

ROE

-118.84%

P/VP

-27.29

CAH - Cardinal Health

$226.17 47,96% (12 M)

P/L

30.94

0.91%

ROE

-62.92%

P/VP

-19.47

ABBV - AbbVie

$259.97 14,69% (12 M)

P/L

72.88

2.63%

ROE

-106.44%

P/VP

-77.57

MRK - Merck & Co.

$143.18 65,85% (12 M)

P/L

110.80

2.36%

ROE

7.56%

P/VP

8.37

AZN - AstraZeneca

$156.59 --6,84% (12 M)

P/L

18.71

2.06%

ROE

25.77%

P/VP

4.82

PFE - Pfizer

$27.48 7,47% (12 M)

P/L

36.14

6.26%

ROE

5.07%

P/VP

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12 M)

P/L

13.14

4.20%

ROE

41.59%

P/VP

5.46

Frequently Asked Questions

What is the price of Ironwood Pharmaceuticals (IRWD) today?

The current price of Ironwood Pharmaceuticals (IRWD) is $3.62. The stock began the year trading around $3.37 and is currently priced at $3.62. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Ironwood Pharmaceuticals (IRWD) pay dividends?

Ironwood Pharmaceuticals (IRWD) did not pay dividends over the past year.

Is Ironwood Pharmaceuticals (IRWD) a good investment?

Ironwood Pharmaceuticals (IRWD) is currently trading at $3.62 with a P/E ratio of 4.58. This represents a 16,638% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 133.55%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ironwood Pharmaceuticals (IRWD) stock?

You can buy Ironwood Pharmaceuticals (IRWD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol IRWD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Ironwood Pharmaceuticals (IRWD) yield today?

Over the past month, Ironwood Pharmaceuticals (IRWD) has returned -15.22% — 133.55% over the past year, and -72.84% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Ironwood Pharmaceuticals (IRWD) today at the current price of $3.62 your total investment would be $362.01.

Based on historical performance, the investment would have grown to approximately:

$845.47 after 1 year
$98.32 after 5 years
$83.59 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IRWD

Ironwood Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IRWD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING IRWD WITH OTHER STOCK

ABOUT Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Inc.

United States

28 years

2010

674

PROFIT X PRICE IRWD

Financial Results IRWD

IRWD cash flow

Asset, Revenue and Profit Growth - IRWD

IRWD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions